I've held this company for a number of years.  It is finally generating income to be at about a breakeven point.  They went from a profit one year ago to a small loss 6 months ago.  They are expanding the business in an area that is rapidy growing.  Alzheimers and dementia are affecting millions of people worldwide and the numbers are growing, as is public awarness.  This company has devleoped computerized tests to determine the level of affectiveness new treatments and drugs have on patients.  The price has come back quite a bit from a high of 1.30+ more than a year ago to a low of 65 just this week.  I think now is a good entry proint for a buy and hold comany.